Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisham Mohammed

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Leukemia|December 16, 2022
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitorsTheodore P Braun, Joseph Estabrook, Zachary Schonrock, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Cell Reports|February 14, 2013
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factorHisham Mohammed, Clive D'Santos, Aurelien A Serandour, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Nature|December 13, 2019
Multi-omics profiling of mouse gastrulation at single-cell resolutionRicard Argelaguet, Stephen J Clark, Hisham Mohammed, et al.
Science Translational Medicine|January 8, 2025
Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in <i>RUNX1</i>-familial platelet disorderMona Mohammadhosseini, Trevor Enright, Adam Duvall, et al.
Cancer Research|August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerAgostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Nature|July 9, 2015
Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Leukemia|December 16, 2022
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitorsTheodore P Braun, Joseph Estabrook, Zachary Schonrock, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Cell Reports|February 14, 2013
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factorHisham Mohammed, Clive D'Santos, Aurelien A Serandour, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Journal for Immunotherapy of Cancer|March 18, 2025
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancerJulio C Tinoco, Harmony I Saunders, Lauryn Rose Werner, et al.
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Nature|December 13, 2019
Multi-omics profiling of mouse gastrulation at single-cell resolutionRicard Argelaguet, Stephen J Clark, Hisham Mohammed, et al.
Science Translational Medicine|January 8, 2025
Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in <i>RUNX1</i>-familial platelet disorderMona Mohammadhosseini, Trevor Enright, Adam Duvall, et al.
Cancer Research|August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerAgostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Nature|July 9, 2015
Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
Pageof 9